Recombinant full-length human IgG1s targeting hormone-refractory prostate cancer
- 7 June 2007
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 85 (10) , 1113-1123
Abstract
We have used a naive human single-chain fragment variable (scFv) library as a source of random shape repertoire to directly probe the altered surface chemistry of tumor cells. We reported previously the identification of more than 90 internalizing phage monoclonal antibodies targeting prostate cancer cells, including those that are hormone refractory. In this report, we describe the conversion of a panel of those scFvs into full-length human immunoglobulins (IgGs) and show that tumor specificity is retained. We have further shown that antibodies isolated from a naive phage display library can nevertheless be of high affinity towards target tumor cells. In addition, full-length IgGs retain the functionality of parental scFvs including the ability to rapidly enter target cells through receptor-mediated endocytosis and thereby to mediate efficient and specific intracellular payload delivery to tumor cells. We have used recombinant IgGs to immunoprecipitate target antigens and analyzed their molecular composition by mass spectrometry. We have identified one target antigen as activated leukocyte cell adhesion molecule (ALCAM)/MEMD/CD166 and have further studied tissue specificity of this internalizing ALCAM epitope by immunohistochemistry. Our study shows that cell type-specific internalizing human antibody can be readily identified from a naive phage antibody display library, characterized with regards to sequence, affinity, tissue specificity, and antigen identity, and modified genetically and chemically to generate various forms of targeted therapeutics.Keywords
This publication has 51 references indexed in Scilit:
- Isolation of scFvs to In Vitro Produced Extracellular Domains of EGFR Family MembersCancer Biotherapy and Radiopharmaceuticals, 2005
- Quantitative Immuno-Positron Emission Tomography Imaging of HER2-Positive Tumor Xenografts with an Iodine-124 Labeled Anti-HER2 DiabodyCancer Research, 2005
- Preparation and Properties of 99mTc(CO)3+-Labeled N,N-Bis(2-pyridylmethyl)-4-aminobutyric AcidBioconjugate Chemistry, 2004
- A Single Treatment of Yttrium-90-labeled CHX-A″–C6.5 Diabody Inhibits the Growth of Established Human Tumor Xenografts in Immunodeficient MiceCancer Research, 2004
- A Human Immunoglobulin G1 Antibody Originating from an in Vitro-Selected Fab Phage Antibody Binds Avidly to Tumor-Associated MUC1 and Is Efficiently InternalizedThe American Journal of Pathology, 2002
- Towards proteome-wide production of monoclonal antibody by phage displayJournal of Molecular Biology, 2002
- Delineation of prognostic biomarkers in prostate cancerNature, 2001
- CHO expression of a novel human recombinant IgG1 anti-RhD antibody isolated by phage displayBritish Journal of Haematology, 2000
- Selection of tumor-specific internalizing human antibodies from phage librariesJournal of Molecular Biology, 2000
- Toward Selection of Internalizing Antibodies from Phage LibrariesBiochemical and Biophysical Research Communications, 1999